SHA:601607 Market Cap

SHA:601607 has a market cap or net worth of 55.41 billion as of March 25, 2026. Its market cap has decreased by -14.34% in one year.

Market Cap

55.41B

Enterprise Value

83.61B

Revenue

280.69B

Ranking

n/a

PE Ratio

10.84

Stock Price

16.51

Market Cap Chart

Since August 20, 2004, SHA:601607's market cap has increased from 2.45B to 55.41B, an increase of 2,159.81%. That is a compound annual growth rate of 15.52%.

Market Cap History

Date	Market Cap	% Change
Mar 25, 2026	55.39B	-6.46%
Dec 31, 2025	59.22B	-14.67%
Dec 31, 2024	69.40B	23.68%
Dec 29, 2023	56.11B	-6.60%
Dec 30, 2022	60.07B	21.91%
Dec 31, 2021	49.28B	3.76%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Guangzhou Baiyunshan Pharmaceutical Holdings Company	35.98B
Jointown Pharmaceutical Group	25.23B
China National Medicines Corporation	21.71B
Liaoning Cheng Da	17.13B
China Meheco Group	14.96B
China National Accord Medicines Corporation	13.06B
Qingdao Baheal Medical INC.	12.18B
C.Q. Pharmaceutical Holding	9.45B

Market Cap Rankings